Theorem Clinical Research

CDISC

CDISC, TransCelerate release new standards for diabetes, cardiovascular disease

Wednesday, November 26, 2014 11:45 AM

The Clinical Data Interchange Standards Consortium (CDISC), a global nonprofit, and King of Prussia, Pa.-based nonprofit TransCelerate BioPharma have made available therapeutic area standards for diabetes and cardiovascular (CV) disease areas through the Coalition for Accelerating Standards and Therapies (CFAST), a joint initiative of CDISC and the Critical Path Institute (C-Path).

More... »

Quest Diagnostics

Accenture launches Accelerated R&D Services

Friday, July 12, 2013 02:05 PM

Accenture, a global management consulting, technology services and outsourcing company, has launched the Accenture Accelerated R&D Services, a business service focused on delivering streamlined and integrated R&D functions to help pharmaceutical companies bring new medications to patients using a more collaborative approach. Accenture is investing more than $200 million to deliver this fully-integrated, technology-enabled global business service.

More... »


CDISC names additions to board of directors

Friday, January 25, 2013 12:27 PM

CDISC, a global, open, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata, has named five highly qualified individuals that will add invaluable expertise to the CDISC board of directors (BoD) for a three-year term beginning this month (2013–2016): Dr. Carolyn Compton, Michael Glickman, Dr. Douglas Peddicord, Stephen Pyke and John Speakman.

More... »

10 pharmas form nonprofit TransCelerate to accelerate R&D of new medicines

Wednesday, September 19, 2012 02:46 PM

Ten biopharmaceutical companies have formed a non-profit organization, TransCelerate BioPharma, to accelerate the development of new medicines. Participants include Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi.

More... »

C-Path and CDISC launch CFAST

Friday, September 14, 2012 12:35 PM

The Clinical Data Interchange Standards Consortium (CDISC), a global non-profit charitable organization, and Critical Path Institute (C-Path), a Tucson, Ariz.-based non-profit organization committed to improving human health and well-being, have launched their joint Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.

More... »

DATATRAK named CDISC Registered Solutions Provider

Tuesday, December 6, 2011 01:28 PM
DATATRAK International has been recognized as a CDISC Registered Solutions Provider. DATATRAK has been registered as a CDISC consultant, system integrator and subject matter expert in the following CDISC standards: Clinical Data Acquisition Standards Harmonization (CDASH); Laboratory Data Model (LAB); Operational Data Model (ODM); Study Data Tabulation Model (SDTM).

More... »

Rebecca Kush to serve on HITS Standards Committee

Wednesday, July 20, 2011 11:48 AM

Rebecca Daniels Kush has been invited to serve on the HIT Standards Committee, a federal advisory committee that makes recommendations to the national coordinator on standards, implementation specifications and certification criteria for the electronic exchange and use of health information for the purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee.

More... »

Nextrials Gets CDISC Approval

Wednesday, March 24, 2010 08:47 AM

Nextrials, a clinical research software and services company, has been approved by the Clinical Data Interchange Standards Consortium (CDISC) as one of 15 registered solutions providers. It is the only company offering an electronic data capture (EDC) product supporting the CDISC Healthcare Link Initiative.

More... »

Guest Commentary: CDASH—The Final Piece in the End-to-End eClinical Interoperability Puzzle

Friday, October 24, 2008 11:00 AM

By Douglas Bain, vice president, Global Operational Excellence, Medidata Solutions Worldwide

More... »


CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs